Navigation Links
Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential
Date:2/9/2011

ients with mucositis, ProLindac™, a second generation DACH Platinum in Phase 2 clinical testing of patients with ovarian cancer, and Thiarabine™, a novel nucleoside analog that has demonstrated both pre-clinical and clinical activity in certain cancers; currently in a Phase 1/2a trial in hematological malignancies at M.D. Anderson Cancer Center in Houston, Texas.  

The company also has other advanced drug delivery technologies including CobaCyte™-mediated targeted delivery and CobOral-oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism.  For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: our cash burn rate, clinical trial plans and timelines and clinical results for ProLindac, MuGard, Thiarabine and Cobalamin and other product candidates, our ability to achieve clinical and commercial success and our ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited to Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.Contact: Company

Contact: Investor Rel
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ness County Hospital Selects ChartAccess® Comprehensive EHR from Prognosis Health Information Systems
2. Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
3. Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems
4. Medicare Patients Report Problems With Access to Medically Required Equipment and Services Under Controversial Competitive Bidding System
5. Access MediQuip Names Prakash Patel Chief Executive Officer
6. Tibotec Signs Multiple Agreements With Generic Manufacturers to Provide Access to New HIV Treatment
7. HeartWare Receives Third Patient Allotment From FDA - Authorizing 94 Additional Patients - Under Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial
8. EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Centers Selection of the OnCore Clinical Research Management System
9. AccessClosure Announces Launch of New Mynx Cadence™ Vascular Closure Device
10. Nationwide Launch of Arstasis One Access Device Provides Cath Labs Across the U.S. an Alternative to Standard Arteriotomies and Vascular Closure Implants
11. Critical Care Nurses Do Not Have Access to Tools They Need to Treat Sepsis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Therapeutics, Inc. (Nasdaq: OREX ) today announced that ... Healthcare Conference in New York . The ... 11 a.m. Eastern Time. To listen to the live webcast ... Relations section of the Company,s Web site at www.orexigen.com ... the event. About Orexigen® Therapeutics Orexigen Therapeutics, ...
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   ... a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities ... for the District of Massachusetts . ... officers violated the Securities Exchange Act of 1934 (the ... 2013 (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... (SP6800).  Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22.  The ... commercial audio-visual technologies into new and novel functionalities for ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... , , , Letters ... , DES PLAINES, Ill., Sept. 10 The American Brain Tumor ... and creative research ideas for solving the challenges of brain tumor diagnosis and ... scientific breakthroughs over the past decade resulting in better treatments and longer lives ...
... EMERYVILLE, Calif., Sept. 10 NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: ... clinical stage company developing novel anti-infective compounds for the treatment ... fungal infections, announced today the start of a Phase 2a ... , , NovaBay,s partner in ...
Cached Medicine Technology:American Brain Tumor Association Calls for Discovery Research 2NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 2NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 3NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 4
(Date:5/19/2013)... Daily Gossip reporters have subjected Joel Marion and Brett ... Fat to a close analysis with the intention to ... is a detailed explanation of the diet suggested by ... two nutritionists have discovered during their research that there is ... and expenditure of our body, that is, the leptin hormone. ...
(Date:5/19/2013)... Reporter , , SATURDAY, May 18 (HealthDay News) -- ... disease overcome the fatigue and decreased muscle strength ... new research. Extra vitamin D "was associated ... greater quality of life and the ability to ... a research dietitian and doctoral candidate at Trinity ...
(Date:5/19/2013)... May 19, 2013 People in Minnesota have ... Altman Fitness is offering its 28 Day Fat Loss Formula. ... from the comfort of their own home. The product sells ... More information can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , ... leave their houses now, but after using the 28 Day ...
(Date:5/19/2013)... Los Angeles, California (PRWEB) May 19, 2013 ... more damage than just losing sleep, or annoying your ... 9, 2013 report by CNY Central (“Snoring and Teeth ... a certain type of teeth grinding can be hard ... around 12 million Americans, and one of its symptoms ...
(Date:5/19/2013)... Fat Burning Furnace developed by Rob Poulos ... with fat burning diet plans, training workouts, ... Furnace package, people will receive the Fat Burning Furnace ... The Fat Burning Furnace manual includes fat loss knowledge, ... mass. In addition, this book covers step-by-step instructions, techniques ...
Breaking Medicine News(10 mins):Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2
... HealthDay Reporter , MONDAY, Feb. 28 (HealthDay News) -- Instructions ... sometimes taking an average of seven pills a day, may ... many patients don,t realize that they can take several medications ... easy to grasp are sorely needed, the researchers added. ...
... the failure of enzymes to break down specific kinds of ... severe physical and neurological problems and sometimes early death. ... of the Journal of Biological Chemistry , researchers at ... by Jeffrey D. Esko, PhD, professor in the Department of ...
... Researchers at the Cummings School of Veterinary Medicine have received ... Syndrome (HUS), a potentially fatal outcome of E. coli ... children. HUS is caused by the forms of ... for about 100,000 annual cases of illness in the United ...
... WASHINGTON, February 28, 2011) Results from a study ... American Society of Hematology reveal a close relationship between ... arteries carrying blood from the heart to the lungsand ... (known as myeloid abnormalities). The study, which was ...
... , MONDAY, Feb. 28 (HealthDay News) -- A ... of depression are less likely than other heart attack patients ... analyzed data on 6,874 heart attack patients admitted to 96 ... March 2005. Of these patients, 680 had a history of ...
... Kansas State University chemistry professor has been selected as ... promising young scholar, particularly in the research areas of ... professor of chemistry, has received the two-year $50,000 award, ... early-career scientists and scholars as a way to recognize ...
Cached Medicine News:Health News:Confusion Over Drug Dosing Common for Seniors 2Health News:Confusion Over Drug Dosing Common for Seniors 3Health News:New marker found for Sanfilippo disease 2Health News:Tufts receives patent for antibody treatment against hemolytic uremic syndrome 2Health News:Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities 2Health News:Heart Patients With Depression Often Find ER Delays 2Health News:K-State chemist's work brings more national recognition as promising early-career scientist 2
... The OSOM Ultra Strep A Test is ... Technology (DLT)**. DLT uses antibody labeled color ... the test device. DLT allows greater sensitivity ... sacrificing specificity. In the test procedure, a ...
... The female Fertell test is an easy ... that measures ovarian reserve by means of determining ... an in-stream urine sample. The test is performed ... 3 of the menstrual cycle) and is similar ...
... The Cholestech GDX System delivers an unmatched ... the ideal solution for assessing and monitoring a ... product demo, click here ., ,The CLIA-waived ... delivers A1C results in less than 5 minutes. ...
... using patented, innovative technology, measures a complete ... only 5 minutes from a simple fingerstick. ... get immediate liver function results. The scope ... only advantage to healthcare providers. The physician, ...
Medicine Products: